Health Catalyst Form 144: 26,970 Restricted Shares to Sell

Health Catalyst, Inc. reported a Form 144 for restricted common stock sales by an individual associated with compensation shares.

Accepted by SEC EDGAR 03/02/2026 - 07:17 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Health Catalyst, Inc. reported a Form 144 for restricted common stock sales by an individual associated with compensation shares. The filing lists 26,970 restricted shares proposed to be sold on 03/02/2026 through Morgan Stanley Smith Barney LLC on Nasdaq. The filing also discloses prior sales in the past three months: 20,619 shares sold on 12/01/2025 and 7,522 shares sold on 02/26/2026, both identified as restricted stock transactions by Jason Alger.

Insights

Equity Compensation Analyst

Form 144 shows planned resale of restricted compensation shares and recent related disposals.

The filing lists 26,970 restricted shares proposed for sale on 03/02/2026 through Morgan Stanley Smith Barney LLC, labeled as compensation-related restricted stock. The document names Jason Alger for recent restricted stock sales.

The excerpt records two prior restricted stock dispositions of 20,619 shares on 12/01/2025 and 7,522 shares on 02/26/2026, with per-transaction dollar figures shown in the filing. Timing and exact proceeds treatment for the proposed sale are described by the sale date and broker listing.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the HCAT Form 144 report?

The Form 144 reports a proposed resale of 26,970 restricted shares of common stock to be sold on 03/02/2026. It also lists two recent restricted stock sales by the same reporting individual in the prior three months.

Who is the named seller on the HCAT Form 144?

The filing identifies Jason Alger as the reporting individual for recent restricted stock sales and as associated with the compensation-related shares planned for resale on 03/02/2026.

What broker is handling the proposed HCAT sale?

The proposed resale on 03/02/2026 is listed with Morgan Stanley Smith Barney LLC at 1 New York Plaza, New York, NY, as the broker-dealer on the Form 144 excerpt.

How many HCAT shares were sold in the past three months per the filing?

The filing shows two prior restricted stock disposals: 20,619 shares on 12/01/2025 and 7,522 shares on 02/26/2026, both recorded in the Form 144 excerpt.

Are the shares described as compensation-related in the HCAT filing?

Yes; the 26,970 restricted shares listed for proposed sale on 03/02/2026 are labeled as Restricted Stock and tied to Compensation in the filing excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001839111
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Health Catalyst, Inc.
SEC File Number	001-38993
Address of Issuer	10897 S River Front Pkwy #300 South Jordan UTAH 84095
Phone	8553096800
Name of Person for Whose Account the Securities are To Be Sold	Jason Alger
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC 1 New York Plaza, 38th Floor New York NY 10004	26970	44767.5	70730884	03/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/02/2026	Restricted Stock	Health Catalyst, Inc.			26970	03/02/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Jason Alger c/o 10897 South River From Parkway #100 South Jordan UT 84095	Restricted Stock	12/01/2025	20619	59799.22
Jason Alger c/o 10897 South River From Parkway #100 South Jordan UT 84095	Restricted Stock	02/26/2026	7522	13146.95

144: Remarks and Signature

Remarks
Date of Notice	03/02/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Jason Alger
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)